Sökning: WFRF:(Claus Rainer) >
c-Jun-N-terminal ph...
c-Jun-N-terminal phosphorylation regulates DNMT1 expression and genome wide methylation in gliomas
-
- Heiland, Dieter H. (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
- Ferrarese, Roberto (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
- Claus, Rainer (författare)
- Univ Freiburg, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany.
-
visa fler...
-
- Dai, Fangping (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
- Masilamani, Anie P. (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
- Kling, Eva (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
- Weyerbrock, Astrid (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
- Kling, Teresia (författare)
- Uppsala universitet,Neuroonkologi,Science for Life Laboratory, SciLifeLab
-
- Nelander, Sven (författare)
- Uppsala universitet,Neuroonkologi,Science for Life Laboratory, SciLifeLab
-
- Carro, Maria S. (författare)
- Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany.;Univ Freiburg, Fac Med, Freiburg, Germany.
-
visa färre...
-
Univ Freiburg, Med Ctr, Dept Neurosurg, Freiburg, Germany;Univ Freiburg, Fac Med, Freiburg, Germany. Univ Freiburg, Med Ctr, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany. (creator_code:org_t)
- 2016-12-28
- 2017
- Engelska.
-
Ingår i: Oncotarget. - : Impact Journals, LLC. - 1949-2553. ; 8:4, s. 6940-6954
- Relaterad länk:
-
http://www.oncotarge...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- High-grade gliomas (HGG) are the most common brain tumors, with an average survival time of 14 months. A glioma-CpG island methylator phenotype (G-CIMP), associated with better clinical outcome, has been described in low and high-grade gliomas. Mutation of IDH1 is known to drive the G-CIMP status. In some cases, however, the hypermethylation phenotype is independent of IDH1 mutation, suggesting the involvement of other mechanisms. Here, we demonstrate that DNMT1 expression is higher in low-grade gliomas compared to glioblastomas and correlates with phosphorylated c-Jun. We show that phospho-c-Jun binds to the DNMT1 promoter and causes DNA hypermethylation. Phospho-c-Jun activation by Anisomycin treatment in primary glioblastoma-derived cells attenuates the aggressive features of mesenchymal glioblastomas and leads to promoter methylation and downregulation of key mesenchymal genes (CD44, MMP9 and CHI3L1). Our findings suggest that phospho-c-Jun activates an important regulatory mechanism to control DNMT1 expression and regulate global DNA methylation in Glioblastoma.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
Nyckelord
- Glioblastoma
- G-CIMP
- DNMT1
- p-c-Jun
- mesenchymal
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Heiland, Dieter ...
-
Ferrarese, Rober ...
-
Claus, Rainer
-
Dai, Fangping
-
Masilamani, Anie ...
-
Kling, Eva
-
visa fler...
-
Weyerbrock, Astr ...
-
Kling, Teresia
-
Nelander, Sven
-
Carro, Maria S.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Cell och molekyl ...
- Artiklar i publikationen
-
Oncotarget
- Av lärosätet
-
Uppsala universitet